Predictive value for future arrhythmic events of fractal dimension, a measure of time clustering of ventricular premature complexes, after myocardial infarction. CAST Investigators. Cardia Arrhythmia Suppression Trial.
暂无分享,去创建一个
K M Stein | J. Anderson | K. Stein | L. Karagounis | F. Moreno | L A Karagounis | R Ledingham | J L Anderson | R. Ledingham | F L Moreno | A Hallstrom | A. Hallstrom
[1] P Kligfield,et al. Computer‐Assisted Analysis of Holter Recordings , 1990, Annals of the New York Academy of Sciences.
[2] G. Diamond,et al. Fascinating rhythm: a primer on chaos theory and its application to cardiology. , 1990, American heart journal.
[3] J. Fleiss,et al. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. , 1993, Circulation.
[4] A. Winfree,et al. Sudden Cardiac Death: A Problem in Topology , 1983 .
[5] Leon Glass,et al. Complex cardiac rhythms , 1987, Nature.
[6] Jørgen K. Kanters,et al. Lack of Evidence for Low‐Dimensional Chaos in Heart Rate Variability , 1994, Journal of cardiovascular electrophysiology.
[7] A. Goldberger,et al. Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence. , 1992, JAMA.
[8] H. Greene,et al. The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators. , 1991, Statistics in medicine.
[9] P Kligfield,et al. Fractal clustering of ventricular ectopy in dilated cardiomyopathy. , 1990, The American journal of cardiology.
[10] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .
[11] S L Winters,et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. , 1989, Journal of the American College of Cardiology.
[12] D. Wyse,et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy. , 1991, Journal of the American College of Cardiology.
[13] T. Bair,et al. Fractal dimension predicts arrhythmia recurrence in patients being treated for life-threatening ventricular arrhythmias. ESVEM Investigators. , 1995, Journal of electrocardiology.
[14] Robert Lemery,et al. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.
[15] P. Denes,et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arryhthmic events in the postinfarction period , 1995 .
[16] P. Grassberger,et al. Measuring the Strangeness of Strange Attractors , 1983 .
[17] P Kligfield,et al. Application of fractal geometry to the analysis of ventricular premature contractions. , 1990, Journal of electrocardiology.
[18] P. Kligfield,et al. Fractal clustering of ventricular ectopy and sudden death in mitral regurgitation. , 1992, Journal of electrocardiology.
[19] N Lippman,et al. Fractal rhythms of the heart. , 1992, Journal of electrocardiology.
[20] C. Furberg,et al. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. , 1987, Journal of the American College of Cardiology.
[21] James Gleick. Chaos: Making a New Science , 1987 .
[22] J. Bigger,et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. , 1991, Journal of the American College of Cardiology.
[23] D. T. Kaplan,et al. Chaos in Cardiology , 1991 .
[24] M Huther,et al. Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial. , 1995, Journal of the American College of Cardiology.
[25] H L Greene,et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.
[26] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[27] W. Rogers,et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). , 1993, JAMA.
[28] J P Miller,et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.
[29] D. Cox. Regression Models and Life-Tables , 1972 .
[30] Benoit B. Mandelbrot,et al. Fractal Geometry of Nature , 1984 .
[31] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.